Urolithin as a Converging Scaffold Linking Ellagic acid and Coumarin Analogues: Design of Potent Protein Kinase CK2 Inhibitors

Cancer; Drug design; Kinase inhibitors; Protein kinase CK2; UrolithinA; Apoptosis; Binding Sites; Casein Kinase II; Catalytic Domain; Cell Line, Tumor; Coumarins; Crystallography, X-Ray; Drug Design; Ellagic Acid; Humans; Protein Kinase Inhibitors; Pharmacology, Toxicology and Pharmaceutics (all); Organic Chemistry; Molecular Medicine